Sven Klussmann
Directeur Technique/Scientifique/R&D chez NOXXON Pharma AG
Profil
Sven Klussmann was the founder of TME Pharma NV, which was founded in 1997, where he held the title of Chief Scientific Officer.
Currently, he is the Chief Scientific Officer at NOXXON Pharma AG since 1997.
Dr. Klussmann's education includes an undergraduate degree from Freie Universität Berlin.
Postes actifs de Sven Klussmann
| Sociétés | Poste | Début |
|---|---|---|
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Directeur Technique/Scientifique/R&D | 01/01/1997 |
Anciens postes connus de Sven Klussmann
| Sociétés | Poste | Fin |
|---|---|---|
| TME PHARMA N.V. | Fondateur | - |
Formation de Sven Klussmann
| Freie Universität Berlin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| TME PHARMA N.V. | Health Technology |
| Entreprise privées | 1 |
|---|---|
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Health Technology |
